---
title: "Stocks in Play: BriaCell Therapeutics Corp."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292917336.md"
description: "09:53 AM EST - BriaCell Therapeutics Corp. : Announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre, a leading cancer center in Toronto, has joined BriaCell’s ongoing pivotal Phase 3 study of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. BriaCell Therapeutics Corp. shares T.BCT are trading down $0.12 at $5.40."
datetime: "2026-07-16T13:55:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292917336.md)
  - [en](https://longbridge.com/en/news/292917336.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292917336.md)
generator: "portal-rs"
---

# Stocks in Play: BriaCell Therapeutics Corp.

**09:53 AM EST - BriaCell Therapeutics Corp. :** Announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre, a leading cancer center in Toronto, has joined BriaCell’s ongoing pivotal Phase 3 study of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. BriaCell Therapeutics Corp. shares T.BCT are trading **down $0.12** at $5.40.

### Related Stocks

- [BCTX.US](https://longbridge.com/en/quote/BCTX.US.md)
- [BCTXZ.US](https://longbridge.com/en/quote/BCTXZ.US.md)
- [BCTXW.US](https://longbridge.com/en/quote/BCTXW.US.md)
- [BCTXL.US](https://longbridge.com/en/quote/BCTXL.US.md)

## Related News & Research

- [BriaCell says Bria-MEL+ melanoma vaccine candidate hits genetic engineering milestone](https://longbridge.com/en/news/296780600.md)
- [BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ | BCTX Stock News](https://longbridge.com/en/news/296784224.md)
- [VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase](https://longbridge.com/en/news/296932909.md)
- [Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.](https://longbridge.com/en/news/296643850.md)
- [Eikon Therapeutics Eyes Safer PARP1 Cancer Treatments With EIK1003, EIK1004](https://longbridge.com/en/news/296680419.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**